Nanomaterials for Diagnosis, Treatment, and Prevention of Human Cutaneous Leishmaniasis: A Review

[1]  Hajar Q. Alijani,et al.  Plant-mediated synthesis of sphalerite (ZnS) quantum dots, Th1-Th2 genes expression and their biomedical applications , 2023, South African Journal of Botany.

[2]  I. Sharifi,et al.  Synthesis and physicochemical characterization of Zn-Al layered double hydroxides (LDHs) as a delivery system for amphotericin B: In vitro and in silico antileishmanial study. , 2023, Heliyon.

[3]  F. Din,et al.  Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis , 2023, Drug delivery.

[4]  C. Kiparissides,et al.  Immunoinformatics Approach to Design a Multi-Epitope Nanovaccine against Leishmania Parasite: Elicitation of Cellular Immune Responses , 2023, Vaccines.

[5]  Han‐Gon Choi,et al.  Mannosylated imiquimod-terbinafine co-loaded transethosomes for cutaneous leishmaniasis; assessment of its anti-leishmanial potential, in vivo safety and immune response modulation. , 2022, Biomaterials advances.

[6]  A. Díez-Pascual,et al.  Emulgel-loaded mannosylated thiolated chitosan-coated silver nanoparticles for the treatment of cutaneous leishmaniasis. , 2022, International journal of biological macromolecules.

[7]  B. Verrier,et al.  Polylactide Nanoparticles as a Biodegradable Vaccine Adjuvant: A Study on Safety, Protective Immunity and Efficacy against Human Leishmaniasis Caused by Leishmania Major , 2022, Molecules.

[8]  F. Din,et al.  Statistical optimization of co-loaded rifampicin and pentamidine polymeric nanoparticles for the treatment of cutaneous leishmaniasis , 2022, Journal of Drug Delivery Science and Technology.

[9]  Salman Khan,et al.  Macrophage targeting of nitazoxanide-loaded transethosomal gel in cutaneous leishmaniasis , 2022, Royal Society Open Science.

[10]  W. Dungchai,et al.  Distance-based paper device using combined SYBR safe and gold nanoparticle probe LAMP assay to detect Leishmania among patients with HIV , 2022, Scientific Reports.

[11]  W. Alves,et al.  Development and Validation of a SERS-Based Serological Test Combined with PLS-DA Method for Leishmaniasis Detection , 2022, ACS Applied Electronic Materials.

[12]  S. Töz,et al.  The Designing of a Gel Formulation with Chitosan Polymer Using Liposomes as Nanocarriers of Amphotericin B for a Non-invasive Treatment Model of Cutaneous Leishmaniasis , 2022, Acta Parasitologica.

[13]  A. Hashemi,et al.  Potential therapeutic effects of curcumin coated silver nanoparticle in the treatment of cutaneous leishmaniasis due to Leishmania major in-vitro and in a murine model , 2022, Journal of Drug Delivery Science and Technology.

[14]  S. Sasidharan,et al.  Gold and silver nanoparticles functionalized with 4',7-dihydroxyflavone exhibits activity against Leishmania donovani. , 2022, Acta tropica.

[15]  G. Mele,et al.  In vitro antileishmanial activity of sustainable anacardic acid and cardol based silver nanoparticles on L. braziliensis. , 2022, International journal of pharmaceutics.

[16]  S. Raj,et al.  Biofunctionalized Chrysin-conjugated gold nanoparticles neutralize Leishmania parasites with high efficacy. , 2022, International journal of biological macromolecules.

[17]  R. Eği̇lmez,et al.  Combination of infra-red light with nanogold targeting macrophages in the treatment of Leishmania major infected BALB/C mice , 2022, Cutaneous and ocular toxicology.

[18]  M. Karamian,et al.  Topical treatment of cutaneous leishmaniasis lesions using quercetin/ artemisia-capped silver nanoparticles ointment: modulation of inflammatory response. , 2022, Acta tropica.

[19]  E. Ricci-Júnior,et al.  Encapsulation of photosensitizer in niosomes for promotion of antitumor and antimicrobial photodynamic therapy , 2021, Journal of Drug Delivery Science and Technology.

[20]  R. Azevedo,et al.  Nanoemulsions with Chloroaluminium Phthalocyanine and Paromomycin for Combined Photodynamic and Antibiotic Therapy for Cutaneous Leishmaniasis , 2021, Infection & chemotherapy.

[21]  F. Riazi-rad,et al.  Combinatorial delivery of antigen and TLR agonists via PLGA nanoparticles modulates Leishmania major-infected-macrophages activation. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[22]  O. Singh,et al.  Nanodiagnostics in leishmaniasis: A new frontiers for early elimination. , 2020, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[23]  M. Fakhar,et al.  Preparation and characterization of a nanoliposomal vaccine of pcLACK candidate against cutaneous leishmaniasis. , 2020, Infectious disorders drug targets.

[24]  V. S. Belo,et al.  Accuracy of diagnostic tests for American tegumentary leishmaniasis: a systematic literature review with meta‐analyses , 2020, Tropical medicine & international health : TM & IH.

[25]  E. Ricci-Júnior,et al.  Development, characterization, and anti-leishmanial activity of topical amphotericin B nanoemulsions , 2020, Drug Delivery and Translational Research.

[26]  S. Şenel,et al.  Chitosan-based particulate systems for drug and vaccine delivery in the treatment and prevention of neglected tropical diseases , 2020, Drug Delivery and Translational Research.

[27]  J. Iqbal,et al.  Cannabis sativa-mediated synthesis of gold nanoparticles and their biomedical properties , 2020 .

[28]  A. Elaissari,et al.  Amphotericin B Loaded Polymeric Nanoparticles for Treatment of Leishmania Infections , 2020, Nanomaterials.

[29]  Qipeng Yuan,et al.  Biogenic metal nanoparticles as a potential class of antileishmanial agents: mechanisms and molecular targets. , 2020, Nanomedicine.

[30]  Dilawar Farhan Shams,et al.  Reactive oxygen species generating photosynthesized ferromagnetic iron oxide nanorods as promising antileishmanial agent. , 2020, Nanomedicine.

[31]  M. Jaafari,et al.  The effect of UV radiation in the presence of TiO2-NPs on Leishmania major promastigotes. , 2020, Biochimica et biophysica acta. General subjects.

[32]  C. R. Fontana,et al.  Efficacy of Photodynamic Therapy Using TiO2 Nanoparticles Doped with Zn and Hypericin Association in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania amazonensis. , 2020, Photodiagnosis and photodynamic therapy.

[33]  F. Din,et al.  Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: passive targeting via topical route. , 2020, Nanomedicine.

[34]  Muhammad Ijaz Khan,et al.  Formulation of topical NLCs to target macrophages for cutaneous leishmaniasis , 2019 .

[35]  A. Seabra,et al.  Nitric oxide-loaded chitosan nanoparticles as an innovative antileishmanial platform. , 2019, Nitric oxide : biology and chemistry.

[36]  W. Setzer,et al.  Bixa orellana L. (Bixaceae) and Dysphania ambrosioides (L.) Mosyakin & Clemants (Amaranthaceae) Essential Oils Formulated in Nanocochleates against Leishmania amazonensis , 2019, Molecules.

[37]  F. Filippin-Monteiro,et al.  Lipid nanoparticles for amphotericin delivery in the treatment of American tegumentary leishmaniasis , 2019, Drug Delivery and Translational Research.

[38]  K. Mehmood,et al.  Antileishmanial activity and cytotoxicity of ZnO-based nano-formulations , 2019, International journal of nanomedicine.

[39]  A. Khamesipour,et al.  Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major: real-time PCR assay plus , 2019, International journal of nanomedicine.

[40]  A. Khamesipour,et al.  Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis , 2019, International journal for parasitology. Drugs and drug resistance.

[41]  Mohammad Hossein Morowvat,et al.  Paromomycin-loaded mannosylated chitosan nanoparticles: Synthesis, characterization and targeted drug delivery against leishmaniasis. , 2019, Acta tropica.

[42]  A. Tedesco,et al.  Topical photodynamic therapy with chloroaluminum phthalocyanine liposomes is as effective as systemic pentavalent antimony in the treatment of experimental cutaneous leishmaniasis. , 2019, Photodiagnosis and photodynamic therapy.

[43]  A. Pentón-Madrigal,et al.  Therapeutic potential of low-cost nanocarriers produced by green synthesis: macrophage uptake of superparamagnetic iron oxide nanoparticles. , 2019, Nanomedicine.

[44]  R. Caldeira,et al.  Development and evaluation of a loop-mediated isothermal amplification assay for rapid detection of Leishmania amazonensis in skin samples. , 2019, Experimental parasitology.

[45]  A. Khamesipour,et al.  Development of topical liposomes containing miltefosine for the treatment of Leishmania major infection in susceptible BALB/c mice. , 2019, Acta tropica.

[46]  L. Ordeix,et al.  Diagnostic performance of a qPCR for Leishmania on stained cytological specimens and on filter paper impressions obtained from cutaneous lesions suggestive of canine leishmaniosis. , 2019, Veterinary dermatology.

[47]  I. Sharifi,et al.  Tioxolone niosomes exert antileishmanial effects on Leishmania tropica by promoting promastigote apoptosis and immunomodulation , 2019, Asian Pacific Journal of Tropical Medicine.

[48]  N. Karunaweera,et al.  A highly sensitive modified nested PCR to enhance case detection in leishmaniasis , 2019, BMC Infectious Diseases.

[49]  I. Sharifi,et al.  Protection induced by Leishmania Major antigens and the imiquimod adjuvant encapsulated on liposomes in experimental cutaneous leishmaniasis. , 2019, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[50]  K. Bouchemal,et al.  Topically Applied Chitosan-Coated Poly(isobutylcyanoacrylate) Nanoparticles Are Active Against Cutaneous Leishmaniasis by Accelerating Lesion Healing and Reducing the Parasitic Load. , 2019, ACS applied bio materials.

[51]  M. Jaafari,et al.  The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice. , 2019, Experimental parasitology.

[52]  A. Khamesipour,et al.  Safety Evaluation of Topical Application of Nano-Liposomal Form of Amphotericin B (SinaAmpholeish) on Healthy Volunteers: Phase I Clinical Trial , 2019, Iranian journal of parasitology.

[53]  B. Arana,et al.  Target Product Profile for a point-of-care diagnostic test for dermal leishmaniases , 2019, Parasite epidemiology and control.

[54]  M. Fakhar,et al.  Potent in vitro antileishmanial activity of a nanoformulation of cisplatin with carbon nanotubes against Leishmania major. , 2019, Journal of global antimicrobial resistance.

[55]  J. M. Hernández,et al.  Transferosomes loaded with chloroaluminum phthalocyanine as cutaneous leishmaniasis therapeutic alternative: permeability and biodistribution in Wistar rats , 2019, Salud Uninorte.

[56]  Z. Abdeen,et al.  Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis , 2018, Drug Delivery and Translational Research.

[57]  R. Ionescu,et al.  Ligand-Capped Ultrapure Metal Nanoparticle Sensors for the Detection of Cutaneous Leishmaniasis Disease in Exhaled Breath. , 2018, ACS sensors.

[58]  C. Buhler,et al.  Evaluation of point-of-care tests for cutaneous leishmaniasis diagnosis in Kabul, Afghanistan , 2018, EBioMedicine.

[59]  Heider Carreño,et al.  Photodynamic therapy using ultradeformable liposomes loaded with chlorine aluminum phthalocyanine against L. (V.) braziliensis experimental models. , 2018, Experimental parasitology.

[60]  B. Rossi-Bergmann,et al.  Nanomedicines for Cutaneous Leishmaniasis , 2018, Leishmaniases as Re-emerging Diseases.

[61]  G. S. Ali,et al.  Comparative antileishmanial efficacy of the biosynthesised ZnO NPs from genus Verbena. , 2018, IET nanobiotechnology.

[62]  K. Karimian,et al.  Investigation of anti-leishmanial efficacy of miltefosine and ketoconazole loaded on nanoniosomes. , 2018, Acta tropica.

[63]  D. Scariot,et al.  Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity. , 2018, Experimental parasitology.

[64]  R. Löbenberg,et al.  Promising nanotherapy in treating leishmaniasis. , 2018, International journal of pharmaceutics.

[65]  A. Khamesipour,et al.  Reduction toxicity of Amphotericin B through loading into a novel nanoformulation of anionic linear globular dendrimer for improve treatment of leishmania major , 2018, Journal of Materials Science: Materials in Medicine.

[66]  A. Khamesipour,et al.  Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis , 2018, Journal of arthropod-borne diseases.

[67]  S. Alonso,et al.  Toward biomedical application of amino-functionalized silicon nanoparticles. , 2018, Nanomedicine.

[68]  S. Robledo,et al.  Solution-combustion synthesis of doped TiO2 compounds and its potential antileishmanial activity mediated by photodynamic therapy. , 2018, Journal of photochemistry and photobiology. B, Biology.

[69]  S. Michaeli,et al.  Antiparasitic Ointment Based on a Biocompatibile Carbon Dot Nanocomposite , 2018 .

[70]  A. Hosseini,et al.  Enhancement of Th1 immune response against Leishmania cysteine peptidase A, B by PLGA nanoparticle , 2018, International immunopharmacology.

[71]  A. Amaral,et al.  Development of Nanoemulsions to Enhance the Antileishmanial Activity of Copaifera paupera Oleoresins , 2018, BioMed research international.

[72]  G. Tavares,et al.  Effects of nanoemulsions prepared with essential oils of copaiba- and andiroba against Leishmania infantum and Leishmania amazonensis infections. , 2018, Experimental parasitology.

[73]  Abida Raza,et al.  Multifunctional theranostic applications of biocompatible green-synthesized colloidal nanoparticles , 2018, Applied Microbiology and Biotechnology.

[74]  E. Rodrigues,et al.  Leishmania (Viannia) braziliensis isolated from the saliva of patients in a cutaneous leishmaniasis-endemic area of northeastern Brazil , 2018, Memorias do Instituto Oswaldo Cruz.

[75]  Mahdi Delavari,et al.  Chitosan-titanium dioxide-glucantime nanoassemblies effects on promastigote and amastigote of Leishmania major. , 2018, International journal of biological macromolecules.

[76]  N. Durán,et al.  Biogenic silver nanoparticles inducing Leishmania amazonensis promastigote and amastigote death in vitro. , 2018, Acta tropica.

[77]  Yutaka Suzuki,et al.  Non-invasive diagnosis of cutaneous leishmaniasis by the direct boil loop-mediated isothermal amplification method and MinION™ nanopore sequencing. , 2018, Parasitology international.

[78]  M. Ardestani,et al.  Induction of Immune Responses by DNA Vaccines Formulated with Dendrimer and Poly (Methyl Methacrylate) (PMMA) Nano-Adjuvants in BALB/c Mice Infected with Leishmania major , 2018, Open access Macedonian journal of medical sciences.

[79]  M. Keighobadi,et al.  Antileishmanial Activity of Lavandula angustifolia and Rosmarinus Officinalis Essential Oils and Nano-emulsions on Leishmania major (MRHO/IR/75/ER) , 2017, Iranian journal of parasitology.

[80]  M. Ré,et al.  Depot Subcutaneous Injection with Chalcone CH8-Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres as a Single-Dose Treatment of Cutaneous Leishmaniasis , 2017, Antimicrobial Agents and Chemotherapy.

[81]  A. Khamesipour,et al.  Cationic liposomes formulated with a novel whole Leishmania lysate (WLL) as a vaccine for leishmaniasis in murine model. , 2017, Immunobiology.

[82]  J. North,et al.  Histopathologic features of cutaneous leishmaniasis and use of CD1a staining for amastigotes in Old World and New World leishmaniasis , 2017, Journal of cutaneous pathology.

[83]  M. Saravanan,et al.  Biosynthesized colloidal silver and gold nanoparticles as emerging leishmanicidal agents: an insight. , 2017, Nanomedicine.

[84]  Santanu Ghosh,et al.  Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: Development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis. , 2017, International journal of biological macromolecules.

[85]  A. Oryan,et al.  Application of nanotechnology in treatment of leishmaniasis: A Review. , 2017, Acta tropica.

[86]  Ali Khademhosseini,et al.  Evolution and Clinical Translation of Drug Delivery Nanomaterials. , 2017, Nano today.

[87]  R. Löbenberg,et al.  Targeting Leishmania amazonensis amastigotes through macrophage internalisation of a hydroxymethylnitrofurazone nanostructured polymeric system. , 2017, International journal of antimicrobial agents.

[88]  W. Setzer,et al.  In Vitro and In Vivo Evaluation of Essential Oil from Artemisia absinthium L. Formulated in Nanocochleates against Cutaneous Leishmaniasis , 2017, Medicines.

[89]  M. Rafailovich,et al.  Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect. , 2017, Acta tropica.

[90]  Shaukat Ali,et al.  Current state and prospects of the phytosynthesized colloidal gold nanoparticles and their applications in cancer theranostics , 2017, Applied Microbiology and Biotechnology.

[91]  B. Abbasi,et al.  Differential effects of in vitro cultures of Linum usitatissimum L. (Flax) on biosynthesis, stability, antibacterial and antileishmanial activities of zinc oxide nanoparticles: a mechanistic approach , 2017 .

[92]  Eduardo Ricci Júnior,et al.  Development and evaluation of zinc phthalocyanine nanoemulsions for use in photodynamic therapy for Leishmania spp. , 2017, Nanotechnology.

[93]  H. Heli,et al.  A label-free, PCR-free and signal-on electrochemical DNA biosensor for Leishmania major based on gold nanoleaves. , 2016, Talanta.

[94]  A. Wu,et al.  Toward High-Efficient Red Emissive Carbon Dots: Facile Preparation, Unique Properties, and Applications as Multifunctional Theranostic Agents , 2016 .

[95]  Muhammad Ali,et al.  Green synthesis of silver nanoparticles via plant extracts: beginning a new era in cancer theranostics. , 2016, Nanomedicine.

[96]  S. Doktorovová,et al.  Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[97]  H. Heli,et al.  Gold nanoparticles-based biosensing of Leishmania major kDNA genome: Visual and spectrophotometric detections , 2016 .

[98]  S. Rafati,et al.  Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against Leishmania in mice model , 2016, Parasite immunology.

[99]  S. Rafati,et al.  Drug Targeting to Macrophages With Solid Lipid Nanoparticles Harboring Paromomycin: an In Vitro Evaluation Against L. major and L. tropica , 2016, AAPS PharmSciTech.

[100]  H. Heli,et al.  An electrochemical genosensor for Leishmania major detection based on dual effect of immobilization and electrocatalysis of cobalt-zinc ferrite quantum dots. , 2016, Talanta.

[101]  Qipeng Yuan,et al.  Phytosynthesis and Antileishmanial Activity of Gold Nanoparticles by Maytenus Royleanus , 2016 .

[102]  Faheem Ullah Khan,et al.  Isatis tinctoria mediated synthesis of amphotericin B-bound silver nanoparticles with enhanced photoinduced antileishmanial activity: A novel green approach. , 2016, Journal of photochemistry and photobiology. B, Biology.

[103]  E. Abamor,et al.  A nanotechnology based new approach for chemotherapy of Cutaneous Leishmaniasis: TIO2@AG nanoparticles - Nigella sativa oil combinations. , 2016, Experimental parasitology.

[104]  Deok-Chun Yang,et al.  Biological Synthesis of Nanoparticles from Plants and Microorganisms. , 2016, Trends in biotechnology.

[105]  N. Karunaweera,et al.  Loop-mediated isothermal amplification assay as a sensitive diagnostic tool for Leishmania donovani infections in Sri Lanka , 2016, The Ceylon medical journal.

[106]  C. Kurachi,et al.  In vitro evaluation of photodynamic therapy using curcumin on Leishmania major and Leishmania braziliensis , 2016, Lasers in Medical Science.

[107]  M. Gazouli,et al.  Detection of Leishmania-specific DNA and surface antigens using a combination of functionalized magnetic beads and cadmium selenite quantum dots. , 2016, Journal of microbiological methods.

[108]  S. Rafati,et al.  Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model , 2016, Applied Microbiology and Biotechnology.

[109]  M. Morilla,et al.  Ultradeformable Archaeosomes for Needle Free Nanovaccination with Leishmania braziliensis Antigens , 2016, PloS one.

[110]  J. Rodríguez-Peralto,et al.  Morphological and immunohistochemical clues for the diagnosis of cutaneous leishmaniasis and the interpretation of CD1a status. , 2016, Journal of the American Academy of Dermatology.

[111]  A. Tedesco,et al.  Evaluation of the efficacy of systemic miltefosine associated with photodynamic therapy with liposomal chloroaluminium phthalocyanine in the treatment of cutaneous leishmaniasis caused by Leishmania (L.) amazonensis in C57BL/6 mice. , 2016, Photodiagnosis and photodynamic therapy.

[112]  A. Misra,et al.  Topical Amphotericin B solid lipid nanoparticles: Design and development. , 2016, Colloids and surfaces. B, Biointerfaces.

[113]  Justin L. Brown,et al.  Polymeric nanoparticles: the future of nanomedicine. , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[114]  S. Abaza.  Applications of nanomedicine in parasitic diseases , 2016 .

[115]  M. Dkhil,et al.  Antioxidant and hepatoprotective role of gold nanoparticles against murine hepatic schistosomiasis , 2015, International journal of nanomedicine.

[116]  R. Schwartz,et al.  Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management. , 2015, Journal of the American Academy of Dermatology.

[117]  Dilawar Farhan Shams,et al.  Visible-light-responsive ZnCuO nanoparticles: benign photodynamic killers of infectious protozoans , 2015, International journal of nanomedicine.

[118]  L. Bačáková,et al.  Nano-structured and functionalized surfaces for cytocompatibility improvement and bactericidal action. , 2015, Biotechnology advances.

[119]  A. Nadhman,et al.  Synthesis in plants and plant extracts of silver nanoparticles with potent antimicrobial properties: current status and future prospects , 2015, Applied Microbiology and Biotechnology.

[120]  Qipeng Yuan,et al.  Silver and gold nanoparticles from Sargentodoxa cuneata: synthesis, characterization and antileishmanial activity , 2015 .

[121]  M. Jabbour,et al.  The immune microenvironment in cutaneous leishmaniasis , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[122]  G. Sahoo,et al.  Study the effects of PLGA-PEG encapsulated Amphotericin B nanoparticle drug delivery system against Leishmania donovani , 2015, Drug delivery.

[123]  H. Schallig,et al.  Cutaneous Leishmaniasis: Recent Developments in Diagnosis and Management , 2015, American Journal of Clinical Dermatology.

[124]  V. Svorcik,et al.  Stabilization of sputtered gold and silver nanoparticles in PEG colloid solutions , 2015, Journal of Nanoparticle Research.

[125]  M. Fakhar,et al.  An improved microculture method for diagnosis of cutaneous leishmaniasis , 2014, Journal of Parasitic Diseases.

[126]  A. Khamesipour,et al.  Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice. , 2014, Experimental parasitology.

[127]  B. Mishra,et al.  Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis. , 2014, Carbohydrate polymers.

[128]  A. Attama,et al.  Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus , 2014, Expert opinion on drug delivery.

[129]  A. Nadhman,et al.  Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives. , 2013, Future medicinal chemistry.

[130]  B. Rothen‐Rutishauser,et al.  Bioavailability of silver nanoparticles and ions: from a chemical and biochemical perspective , 2013, Journal of The Royal Society Interface.

[131]  A. Tedesco,et al.  Leishmanicidal activity of amphotericin B encapsulated in PLGA-DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL/6 mice. , 2013, Experimental parasitology.

[132]  N. Jain,et al.  Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. , 2013, Life sciences.

[133]  Karsten Mäder,et al.  Solid lipid nanoparticles , 2012 .

[134]  A. Ito,et al.  Interaction of miltefosine with intercellular membranes of stratum corneum and biomimetic lipid vesicles. , 2012, International journal of pharmaceutics.

[135]  A. Fahr,et al.  Liposomes in topical photodynamic therapy , 2012, Expert opinion on drug delivery.

[136]  H. Goto,et al.  Cutaneous and mucocutaneous leishmaniasis. , 2012, Infectious disease clinics of North America.

[137]  M. Ghadiri,et al.  Paromomycin loaded solid lipid nanoparticles: Characterization of production parameters , 2011 .

[138]  José-Julián Pérez-Cordero,et al.  Use of a fluorescent stain for evaluating in vitro infection with Leishmania panamensis. , 2011, Experimental parasitology.

[139]  Pegi Ahlin Grabnar,et al.  The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers , 2011, Journal of microencapsulation.

[140]  Rafael M. Maki,et al.  Biosensors for efficient diagnosis of leishmaniasis: innovations in bioanalytics for a neglected disease. , 2010, Analytical chemistry.

[141]  M. Patel,et al.  Development and Evaluation of Liposomes for Topical Delivery of Tacrolimus (Fk-506) , 2010 .

[142]  M. Pinart,et al.  Designing and reporting clinical trials on treatments for cutaneous leishmaniasis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[143]  Rasesh Y Parikh,et al.  Biological synthesis of metallic nanoparticles. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[144]  A. Khamesipour,et al.  Effect of Topical Liposomes Containing Paromomycin Sulfate in the Course of Leishmania major Infection in Susceptible BALB/c Mice , 2009, Antimicrobial Agents and Chemotherapy.

[145]  D. Low,et al.  Optimization of microculture and evaluation of miniculture for the isolation of Leishmania parasites from cutaneous lesions in Peru. , 2008, The American journal of tropical medicine and hygiene.

[146]  R. Murthy,et al.  Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles , 2007, AAPS PharmSciTech.

[147]  M. Joshi,et al.  Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles. , 2007, Advanced drug delivery reviews.

[148]  P. Parola,et al.  Cutaneous leishmaniasis treatment. , 2007, Travel medicine and infectious disease.

[149]  P. Couvreur,et al.  Nanotechnology: Intelligent Design to Treat Complex Disease , 2006, Pharmaceutical Research.

[150]  J. Berman,et al.  Advances in leishmaniasis , 2005, The Lancet.

[151]  J. Drevs,et al.  Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study , 2004, Cancer Chemotherapy and Pharmacology.

[152]  P. Desjeux,et al.  Treatment of cutaneous leishmaniasis among travellers. , 2004, The Journal of antimicrobial chemotherapy.

[153]  E. A. Nunan,et al.  In Vitro Skin Permeation and Retention of Paromomycin from Liposomes for Topical Treatment of the Cutaneous Leishmaniasis , 2004, Drug development and industrial pharmacy.

[154]  Yajiang Yang,et al.  Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[155]  T. Tadakuma,et al.  Protection against Leishmania major infection by oligomannose-coated liposomes. , 2003, Bioorganic & medicinal chemistry.

[156]  C. Hopper,et al.  Photodynamic therapy: a clinical reality in the treatment of cancer. , 2000, The Lancet. Oncology.

[157]  R. Müller,et al.  Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[158]  P. Lehmann,et al.  Photodynamic Diagnosis and Therapy in Dermatology , 1998, Skin Pharmacology and Physiology.

[159]  G. Cevc,et al.  Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. , 1992, Biochimica et biophysica acta.

[160]  J. Poupaert,et al.  Poly(diethylmethylidene Malonate) Nanoparticles As Primaquine Delivery System To Liver , 1992 .

[161]  K. Berg,et al.  THE PHOTODEGRADATION OF PORPHYRINS IN CELLS CAN BE USED TO ESTIMATE THE LIFETIME OF SINGLET OXYGEN , 1991, Photochemistry and photobiology.

[162]  A. Florence,et al.  The preparation and properties of niosomes—non‐ionic surfactant vesicles , 1985, The Journal of pharmacy and pharmacology.

[163]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.

[164]  W. Leishman.  ON THE POSSIBILITY OF THE OCCURRENCE OF TRYPANOSOMIASIS IN INDIA , 1903, The Indian journal of medical research.

[165]  O. Singh,et al.  Therapeutic Leishmaniasis: Recent Advancement and Developments in Nanomedicines , 2019, Nanotechnology in Modern Animal Biotechnology.

[166]  V. Yardley,et al.  AmBisome® treatment of murine cutaneous leishmaniasis: 1 relation between skin pharmacokinetics and efficacy , 2017 .

[167]  K. Katakura,et al.  A rapid molecular diagnosis of cutaneous leishmaniasis by colorimetric malachite green-loop-mediated isothermal amplification (LAMP) combined with an FTA card as a direct sampling tool. , 2016, Acta tropica.

[168]  R. S. Mehdi,et al.  NANOGOLD FOR THE TREATMENT OF ZOONOTIC CUTANEOUS LEISHMANIASIS CAUSED BY LEISHMANIA MAJOR (MRHO/IR/75/ER): AN ANIMAL TRIAL WITH METHANOL EXTRACT OF EUCALYPTUS CAMALDULENSIS , 2011 .

[169]  M. Baptista,et al.  Photodynamic antimicrobial chemotherapy (PACT) for the treatment of malaria, leishmaniasis and trypanosomiasis. , 2011, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[170]  B. Baroli,et al.  Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? , 2010, Journal of pharmaceutical sciences.

[171]  J. Kreuter.  Liposomes and nanoparticles as vehicles for antibiotics , 2005, Infection.

[172]  M. Biel.  Photodynamic therapy in head and neck cancer , 2002, Current oncology reports.

[173]  Joachim Mühling,et al.  Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck , 1999, Lasers in surgery and medicine.